Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Wehkamp

Showing results (11-20 of 122) with videos related to

Pageof 13
Sort By:
International Journal of Medical Microbiology : IJMM|March 22, 2016
Crosstalk between microbiota, pathogens and the innate immune responsesClaudia Günther, Christine Josenhans, Jan Wehkamp
Clinical Endoscopy|October 12, 2017
Endoscopic Balloon Dilation for Crohn's Disease-Associated StricturesThomas Klag, Jan Wehkamp, Martin Goetz
Digestive Diseases (Basel, Switzerland)|November 20, 2013
Defective antibacterial barrier in inflammatory bowel diseaseThomas Klag, Eduard F Stange, Jan Wehkamp
Current Opinion in Gastroenterology|June 5, 2007
Defensins and other antimicrobial peptides in inflammatory bowel diseaseJan Wehkamp, Michael Schmid, Eduard F Stange
Current Opinion in Gastroenterology|November 30, 2006
Defensins and cathelicidins in gastrointestinal infectionsJan Wehkamp, Jürgen Schauber, Eduard F Stange
Annals of Gastroenterology|April 10, 2014
Innate immunity includes defensinsSimon Jäger, Jan Wehkamp, Eduard F Stange
United European Gastroenterology Journal|August 18, 2015
Management of Crohn's disease - are guidelines transferred to clinical practice?Thomas Klag, Eduard F Stange, Jan Wehkamp
Langenbeck'S Archives of Surgery|November 20, 2012
Inflammatory bowel disease: an impaired barrier diseaseSimon Jäger, Eduard F Stange, Jan Wehkamp
World Journal of Gastroenterology|September 14, 2011
From intestinal stem cells to inflammatory bowel diseasesMichael Gersemann, Eduard Friedrich Stange, Jan Wehkamp
Expert Review of Clinical Immunology|September 11, 2010
Innate antimicrobial immunity in inflammatory bowel diseasesJulia Beisner, Eduard F Stange, Jan Wehkamp
Pageof 13

Showing results (11-20 of 122) with videos related to

Sort By:
Pageof 13
International Journal of Medical Microbiology : IJMM|March 22, 2016
Crosstalk between microbiota, pathogens and the innate immune responsesClaudia Günther, Christine Josenhans, Jan Wehkamp
Clinical Endoscopy|October 12, 2017
Endoscopic Balloon Dilation for Crohn's Disease-Associated StricturesThomas Klag, Jan Wehkamp, Martin Goetz
Digestive Diseases (Basel, Switzerland)|November 20, 2013
Defective antibacterial barrier in inflammatory bowel diseaseThomas Klag, Eduard F Stange, Jan Wehkamp
Current Opinion in Gastroenterology|June 5, 2007
Defensins and other antimicrobial peptides in inflammatory bowel diseaseJan Wehkamp, Michael Schmid, Eduard F Stange
Current Opinion in Gastroenterology|November 30, 2006
Defensins and cathelicidins in gastrointestinal infectionsJan Wehkamp, Jürgen Schauber, Eduard F Stange
Annals of Gastroenterology|April 10, 2014
Innate immunity includes defensinsSimon Jäger, Jan Wehkamp, Eduard F Stange
United European Gastroenterology Journal|August 18, 2015
Management of Crohn's disease - are guidelines transferred to clinical practice?Thomas Klag, Eduard F Stange, Jan Wehkamp
Langenbeck'S Archives of Surgery|November 20, 2012
Inflammatory bowel disease: an impaired barrier diseaseSimon Jäger, Eduard F Stange, Jan Wehkamp
World Journal of Gastroenterology|September 14, 2011
From intestinal stem cells to inflammatory bowel diseasesMichael Gersemann, Eduard Friedrich Stange, Jan Wehkamp
Expert Review of Clinical Immunology|September 11, 2010
Innate antimicrobial immunity in inflammatory bowel diseasesJulia Beisner, Eduard F Stange, Jan Wehkamp
Pageof 13